Healthtech Startups

Cygnus Med develops the EndoSphinx, an endovascular access system that provides continuous arterial blood pressure monitoring while eliminating blood loss and preventing clotting inside the guiding catheter during endovascular procedures. The device is aimed at clinicians performing endovascular interventions.

1 investor

Cynapsus is a specialty central nervous system pharmaceutical company developing a fast-acting sublingual thin film for on-demand management of OFF episodes in Parkinson's disease patients. Its lead candidate, APL-130277, is a sublingual formulation of apomorphine intended as an alternative to subcutaneous injection, and had entered Phase 3 clinical development.

1 investor

CynosBio develops and commercializes regenerative medicine products, including cell-based treatments for cartilage damage, joint disorders, and liver disease. The company is based in Japan and pursues global expansion, particularly in the United States.

1 investor

1 investor

Cyrano Video provides subscription-based video production services combining customized hardware, software, and editorial support for healthcare organizations. The platform enables clients to produce video content at scale across multiple formats—in-studio, at-desk, and mobile—for enhanced internal communication, patient engagement, and personalized outreach.

1 investor

CyrenCare provides digital patient intake software that captures clinical information through customizable forms and generates clinician-friendly reports for healthcare providers. The platform supports multilingual service delivery.

1 investor

cystetic Medicines is a drug development company creating an inhaled dry-powder therapy based on an FDA-approved antifungal compound to treat cystic fibrosis, targeting the roughly 10% of patients not helped by existing modulators. The company focuses on accessible, scalable treatment using aerodynamically engineered nanoparticle delivery.

1 investor

Cyta Therapeutics develops polymer-based nanogel therapeutics (IntelliGels) to treat obesity, NASH, type 2 diabetes, and metabolic disorders. The company's lead program, Cyta-001, is a liver-targeted drug delivery system encapsulating a thyroid hormone receptor agonist for metabolic disease management.

1 investor

CytoBioscience develops automated patch clamp instruments (CytoPatch) and offers contract research organization (CRO) services, cell lines, and consumables for electrophysiology and ion channel research. It serves pharmaceutical and life science research customers.

1 investor

Cytodyme builds software for regulatory and quality teams at life science companies to manage post-market reporting, literature reviews, documentation, audits, and submissions. The platform consolidates data from disconnected systems to reduce administrative burden for regulated life science and biotech teams.

1 investor

Cytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.

1 investor

Cytovation develops immunotherapy treatments designed to enhance immune response against various cancer types, with a focus on engineered synthetic peptides and first-in-class therapeutic candidates. The company is built on research foundations from Norwegian academic institutions and serves oncology and immunology markets.

1 investor

Cytrellis develops medical device technologies focused on aesthetic and reconstructive treatments, with expertise spanning dermatology, plastic surgery, and wound healing applications.

1 investor

Cytura Therapeutics is a pharmaceutical company focused on drug discovery and development, with backing from academic research institutions and venture capital firms specializing in biotech and medtech investments.

1 investor

DP Bio Innovations is developing an implantable, bioresorbable medical device that regenerates a damaged esophagus inside the body, intended to treat patients with severe GERD/advanced Barrett's Esophagus, esophageal cancer, and pediatric esophageal defects. The device aims to avoid surgical reconstruction such as gastric pull-up and reduce treatment costs compared to the standard of care.

1 investor

D2Type provides AI-enabled, lifestyle-first diabetes and cardiometabolic care delivered as between-visit clinical support, using proactive monitoring, early detection, and human clinical escalation to complement therapies like GLP-1s. It partners with health systems, employers, health plans, and clinicians to advance value-based care and reduce avoidable admissions and complications.

1 investor

D4C Dental Brands is a dental service organization supporting a network of pediatric dental and orthodontic specialty practices across the United States. It provides business and operational support to affiliated pediatric dentists and orthodontists focused on children's oral health.

1 investor

Dadadoc Healthcare operates a telemedicine service for pediatric care in South Korea, letting patients consult with medical staff in real time and receive prescriptions without visiting a hospital. It also offers a digital health product using a smart thermometer that automatically syncs temperature data to a mobile app for tracking and sharing.

1 investor

Dailyhuman develops science-backed training and approaches validated by top-tier doctors, operators, and researchers for applications in healthcare, education, and research contexts.

1 investor

Daisies is a women's health telemedicine app in Mexico offering a membership that provides access to female doctors across 20+ specialties, including gynecology, psychology, nutrition, general health, and training. It provides on-demand video consultations, digital prescriptions, a shared encrypted medical record, and clinical self-assessments, available 24/7 via mobile.</parameter> <parameter name="hq_country">MX

1 investor

The International Cystic Fibrosis Training Network (ICFTN) provides training, mentorship, and clinical development support to multidisciplinary cystic fibrosis care teams worldwide. It works with patients, families, and care centers to improve clinical processes and patient outcomes in CF care globally.

1 investor

Dalent Medical develops medical devices for Ear, Nose & Throat (ENT) physicians. The company is based in Miami.

1 investor

Dalton Bioanalytics develops comprehensive biochemical analysis of humans in a single test, aimed at advancing preventative healthcare.

1 investor

DaltonTx builds an AI-enabled cloud platform for drug discovery, covering the full lifecycle from data ingestion and model training to molecule generation and experiment prioritisation for both biologics and small molecules. It serves pharma, biotech, and CROs, positioning itself as R&D infrastructure that combines human scientific expertise with machine intelligence.

1 investor